Matches in Wikidata for { <http://www.wikidata.org/entity/Q98216202> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q98216202 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98216202 description "im August 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98216202 description "scientific article published on 02 August 2020" @default.
- Q98216202 description "wetenschappelijk artikel" @default.
- Q98216202 description "наукова стаття, опублікована 2 серпня 2020" @default.
- Q98216202 name "Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)" @default.
- Q98216202 name "Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)" @default.
- Q98216202 type Item @default.
- Q98216202 label "Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)" @default.
- Q98216202 label "Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)" @default.
- Q98216202 prefLabel "Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)" @default.
- Q98216202 prefLabel "Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)" @default.
- Q98216202 P1433 Q98216202-C1E92B59-34E0-4899-A630-B1C8996BEF52 @default.
- Q98216202 P1476 Q98216202-CAC878E1-D7AD-4827-A46E-39E2DC930782 @default.
- Q98216202 P2093 Q98216202-068FEB02-4EBA-4005-AB62-E8D47A71B615 @default.
- Q98216202 P2093 Q98216202-10265C18-C623-410D-BA4A-AFE63FFCF7A1 @default.
- Q98216202 P2093 Q98216202-249C904F-196D-4E41-97B4-B6A03BB07BFB @default.
- Q98216202 P2093 Q98216202-24D98FD6-8064-48B8-BD85-CCA28EF24054 @default.
- Q98216202 P2093 Q98216202-2DB46D5B-DC23-4BF5-BEB7-7A4AFAF5E0B1 @default.
- Q98216202 P2093 Q98216202-36594D6A-89BC-4A7A-A7BA-C785F02FA125 @default.
- Q98216202 P2093 Q98216202-4651C22E-D5B0-4EC0-804B-C890540FD537 @default.
- Q98216202 P2093 Q98216202-4CAED793-DA91-4687-82CE-C8378CF523F2 @default.
- Q98216202 P2093 Q98216202-4DE50367-6D8B-4DB1-B78C-B46768E7541B @default.
- Q98216202 P2093 Q98216202-4E987505-7CFC-42E3-A5AA-A1ED73102F68 @default.
- Q98216202 P2093 Q98216202-600466D4-99F6-4703-8724-FFDC2A81F2B3 @default.
- Q98216202 P2093 Q98216202-7235FA07-FED0-4D2A-BF19-C6D453F36E12 @default.
- Q98216202 P2093 Q98216202-7C074DAD-481E-4B8F-A881-35CD093933A1 @default.
- Q98216202 P2093 Q98216202-7C18E2C8-A2B3-4B2E-84A4-05CE64A64301 @default.
- Q98216202 P2093 Q98216202-C669ECEE-5561-47E0-BF85-53EFEAA961FB @default.
- Q98216202 P2093 Q98216202-CBB27910-F750-42A2-9988-D655F9F368F1 @default.
- Q98216202 P2093 Q98216202-EB5893FE-6077-4B5E-95EA-964EBC987D3F @default.
- Q98216202 P2093 Q98216202-F6945110-51B2-45B9-9B95-A741E1269F0E @default.
- Q98216202 P31 Q98216202-1E1C3001-6C20-4402-96BB-708FE2E1F47D @default.
- Q98216202 P356 Q98216202-1CD2BC13-1E63-403B-97A2-B47DC6D86599 @default.
- Q98216202 P577 Q98216202-FBBA6B15-11E3-4D78-9FB5-7EA923DF2728 @default.
- Q98216202 P698 Q98216202-6091669E-A808-4D8C-AB7F-CBC43ADFA07F @default.
- Q98216202 P356 J.EUO.2020.07.002 @default.
- Q98216202 P698 32758400 @default.
- Q98216202 P1433 Q63882907 @default.
- Q98216202 P1476 "Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)" @default.
- Q98216202 P2093 "Andrew Nguyen" @default.
- Q98216202 P2093 "Andrew O Yam" @default.
- Q98216202 P2093 "Anthony M Joshua" @default.
- Q98216202 P2093 "Arnavaz Danesh" @default.
- Q98216202 P2093 "Arun A Azad" @default.
- Q98216202 P2093 "Bao Ho" @default.
- Q98216202 P2093 "Christopher Rofe" @default.
- Q98216202 P2093 "Edmond M Kwan" @default.
- Q98216202 P2093 "Jesse A Ende" @default.
- Q98216202 P2093 "Joanne Keane" @default.
- Q98216202 P2093 "Kamonwan Kongrak" @default.
- Q98216202 P2093 "Louise Emmett" @default.
- Q98216202 P2093 "Lyn Chan" @default.
- Q98216202 P2093 "Megan Crumbaker" @default.
- Q98216202 P2093 "Peter Eu" @default.
- Q98216202 P2093 "Sarennya Pathmanandavel" @default.
- Q98216202 P2093 "Shikha Sharma" @default.
- Q98216202 P2093 "Trevor J Pugh" @default.
- Q98216202 P31 Q13442814 @default.
- Q98216202 P356 "10.1016/J.EUO.2020.07.002" @default.
- Q98216202 P577 "2020-08-02T00:00:00Z" @default.
- Q98216202 P698 "32758400" @default.